Acumen Pharmaceuticals, Inc. - ABOS Company Short-Term Debt

Acumen Pharma (ABOS) - corporate logo

Acumen Pharmaceuticals (ABOS) possesses significant market influence thanks to its unique ACU193 antibody. The business's success relies on test results and physician recognition. The amount of short-term borrowed capital illustrates financial stability, where 0.02 describes the current status of the metric. The company is racing to create targeted immunotherapy, competing solely on the efficiency of its clinical data.

ABOS (acumenpharm.com) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Acumen Pharmaceuticals, Inc - analytical breakdowns and key metrics (ABOS)

- price and consensus price forecast:
Price Chart Acumen Pharmaceuticals, Inc.|ABOS - Fair Value Consensus
- market capitalization data:
Market Value Acumen Pharmaceuticals, Inc.|ABOS - Total Enterprise Value
- book capitalization data:
Book Value per Share Acumen Pharmaceuticals|ABOS - Book Capitalization|Market Capitalization to Book Value Ratio acumenpharm.com|ABOS - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Acumen Pharmaceuticals|ABOS - Long-Term Debt to Capital|Short-Term Debt to Equity Acumen Pharmaceuticals|ABOS - Company Total Debt|Debts to Book Capitalization Acumen Pharmaceuticals, Inc.|ABOS - Long-Term Debt|Company Short-Term Debt Acumen Pharmaceuticals
Analysis of all company metrics:Acumen Pharmaceuticals, Inc., ABOS
Manufactured products of Acumen Pharmaceuticals

The metric's dynamics reflect the operational efficiency of liquidity management through daily monitoring of liabilities with maturities of up to one year. This indicator captures the short-term credit load, which is critical for Acumen Pharmaceuticals (ABOS) given its dependence on the results of Alzheimer's disease drug trials; therefore, the company's current liabilities allow for an assessment of the biotech's financial stability in the face of competition from pharma behemoths.

Competitor analysis for Acumen Pharmaceuticals

Company Short-Term Debt Biogen (BIIB)|NBIX: Company Short-Term Loans and Borrowings|Company Short-Term Debt RGC|Axsome Corp (AXSM) - Short-Term Debt|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts xenon-pharma.com|Company Short-Term Debts VKTX (Viking Therapeutics, Inc.)|Company Current Liabilities Supernus Pharmaceuticals, Inc. SUPN|Company Current Liabilities CPRX (Catalyst Pharmaceuticals Inc)|Denali Corp - Company Short-Term Debts|HRMY: Company Short-Term Debt|BHVN - Company Current Liabilities|Company Short-Term Debts AMLX|TRVI (Trevi Therapeutics Inc) - Short-Term Debt|Company Short-Term Debt Praxis Medicines (PRAX)|Company Short-Term Indebtedness Anavex Life Sciences Corp (AVXL)|CeriBell, Inc. (CBLL) - Company Current Liabilities|Company Short-Term Loans and Borrowings PRTA (Prothena Corporation plc)|Alector (ALEC) - Company Short-Term Debt|Current Liabilities Annexon Biosciences ANNX|Company Short-Term Debts Omeros Corp. (OMER)|NGNE - Company Short-Term Loans and Borrowings|ACIU: Company Short-Term Debts|VYGR (voyagertherapeutics.com) - Company Short-Term Debts|NMRA - Company Short-Term Debt|Company Short-Term Loans and Borrowings SCLX|Company Short-Term Debt TVGN (Tevogen Bio Holdings, Inc.)|Company Current Liabilities alphacognition.com (ACOG)|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|Company Short-Term Debts inhibikase.com IKT|SAVA: Company Short-Term Debts|ASRT - Company Current Liabilities|Company Short-Term Debts COYA|Short-Term Debt Vistagen|OVID (Ovid Therapeutics Inc) - Company Current Liabilities|Company Short-Term Debts cervomed.com (CRVO)|Company Current Liabilities Alterity Therapeutics|Amount of Current Liabilities clene.com (CLNN)|Company Short-Term Debts PEPG|Short-Term Debt Volume jupiterneurosciences.com JUNS|RLMD: Company Short-Term Debts|ANVS - Company Current Liabilities|GRCE: Company Short-Term Debts|AIFF (Firefly Neuroscience, Inc.) - Company Short-Term Debts|Company Short-Term Debt ANEW Medical|Company Short-Term Debt NRSN|RVPH (Reviva Pharmaceuticals) - Company Short-Term Debt|Short-Term Debt Volume metaviatx.com (MTVA)|Company Short-Term Debts NRXS (NeurAxis)|Company Short-Term Debts Helius Medical Technologies, Inc. HSDT|PASG - Company Short-Term Debts|NEUP: Company Short-Term Debt|Company Short-Term Debt NERV|ATHA (athira.com) - Short-Term Debt|ADXN: Company Short-Term Debt|Short-Term Debt Volume ALZN|Company Short-Term Debt Cyclerion Therapeutics CYCN|Company Short-Term Indebtedness protagenic.com (PTIX)|KTTA: Company Short-Term Debts|CRGT - Short-Term Debt|Avenue Therapeutics, Inc. - Company Current Liabilities|BCLI: Company Short-Term Debts|Company Short-Term Debt Cara Therapeutics, Inc CARA|CHRO (Chromocell) - Company Short-Term Loans and Borrowings|Company Short-Term Debt ELYM (Eliem Therapeutics, Inc.)|Short-Term Debt Intra-Cellular|Company Short-Term Debts LBPH|Company Short-Term Debts Marinus Pharmaceuticals Inc (MRNS)|NKGen - Company Short-Term Debts|NRBO - Company Current Liabilities|Sage Therapeutics, Inc. - Company Current Liabilities|SNPX: Company Short-Term Debts|TRVN (Trevena) - Company Short-Term Debt|Vigil Neuroscience, Inc. (VIGL) - Company Current Liabilities|Company Short-Term Debts WENA (Anew Medical, Inc.)|Short-Term Debt CERE